Cargando…
Synthetic Biology: Emerging Concepts to Design and Advance Adeno‐Associated Viral Vectors for Gene Therapy
Three recent approvals and over 100 ongoing clinical trials make adeno‐associated virus (AAV)‐based vectors the leading gene delivery vehicles in gene therapy. Pharmaceutical companies are investing in this small and nonpathogenic gene shuttle to increase the therapeutic portfolios within the coming...
Autores principales: | Wagner, Hanna J., Weber, Wilfried, Fussenegger, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097373/ https://www.ncbi.nlm.nih.gov/pubmed/33977059 http://dx.doi.org/10.1002/advs.202004018 |
Ejemplares similares
-
Emerging biomedical applications of synthetic biology
por: Weber, Wilfried, et al.
Publicado: (2011) -
The impact of synthetic biology on drug discovery
por: Weber, Wilfried, et al.
Publicado: (2009) -
Adeno-associated viral vectors engineered for macrolide-adjustable transgene expression In mammalian cells and mice
por: Fluri, David A, et al.
Publicado: (2007) -
Biology of adeno-associated viral vectors in the central nervous system
por: Murlidharan, Giridhar, et al.
Publicado: (2014) -
Advances in designing Adeno-associated viral vectors for development of anti-HBV gene therapeutics
por: Mnyandu, Njabulo, et al.
Publicado: (2021)